Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG-Free Melphalan in MM ASCT
NCT02669615Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Nov 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in multiple myeloma (MM), sponsored by Medical College of Wisconsin. Started Nov 2016; status: completed.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02669615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669615.